| 000 | 02615cam a2200373 a 4500 | ||
|---|---|---|---|
| 005 | 20250918004550.0 | ||
| 008 | 090406s2007 enka b 001 0 eng | ||
| 020 | _a0521874904 (hardback) | ||
| 020 |
_a9780521874908 (hardback) _cRM212.28 |
||
| 039 | 9 |
_a200906191605 _bmustaffa _c200904271251 _dmustaffa _y04-06-2009 _zrazalis |
|
| 040 | _aUKM | ||
| 060 |
_aQV736 _b.P536 2007 9 |
||
| 090 | _aQV736.P536 2007 9 | ||
| 245 | 0 | 0 |
_aPharmaceutical innovation : _bincentives, competition, and cost-benefit analysis in international perspective / _cedited by Frank A. Sloan, Chee-Ruey Hsieh |
| 260 |
_aCambridge ; _aNew York : _bCambridge University Press, _c2007 |
||
| 300 |
_axiv, 331 p. : _bill. ; _c24 cm. |
||
| 504 | _aIncludes bibliographical references (p. 293-317) and index | ||
| 505 | 0 | _aIntroduction / Frank A. Sloan and Chee-Ruey Hsieh -- The pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux ... [et al.] -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh ... [et al.] -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh | |
| 650 | 2 |
_aDrug Industry _xeconomics |
|
| 650 | 2 | _aCost-Benefit Analysis | |
| 650 | 2 | _aEconomic Competition | |
| 650 | 2 | _aHealth policy | |
| 650 | 2 |
_aPharmaceutical Preparations _xeconomics |
|
| 650 | 2 |
_aVaccines _xeconomics |
|
| 700 | 1 | _aSloan, Frank A. | |
| 700 | 1 | _aHsieh, Chee-Ruey | |
| 907 |
_a.b14453150 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV736.P536 2007 9 |
||
| 914 | _avtls003404612 | ||
| 990 | _amk | ||
| 991 | _aJabatan Farmasi, KKL | ||
| 998 |
_ad _b2009-06-04 _cm _da _feng _genk _y0 _z.b14453150 |
||
| 999 |
_c437820 _d437820 |
||